Apple prepares Apple Watch ban workaround by disabling blood oxygen tracker

Published



U.S. customs officials have provided Apple a loophole to continue selling Apple Watches in the United States after the tech giant was banned from doing so over a patent dispute.

Officials from the U.S. Customs and Border Protection decided on Friday that Apple could continue to sell the Apple Watch Series 9 and the Apple Watch Ultra 2 in the U.S. if it disabled the pulse oximeter, according to a filing in the U.S. Court of Appeals for the Federal Circuit. The product was initially banned by the International Trade Commission in late December due to a patent dispute between Apple and the medical technology company Masimo over Apple’s implementation of a blood oxygen tracker into the device. While the federal court is still considering Apple’s appeal, the CBP decision could allow Apple to sell devices while the matter is resolved.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.